Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming http://murphylaboratory.com/wp-content/uploads/2022/06/Fine-Tuning-Mybl2-Is-Required-.pdf
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics http://murphylaboratory.com/wp-content/uploads/2022/06/A-library-of-ATTR-amyloidosis-patient-specific-induced-pluripotent-stem-cells-for-disease.pdf
Induced pluripotent stem cell–based mapping of b-globin expression throughout human erythropoietic development http://murphylaboratory.com/wp-content/uploads/2022/06/Induced-pluripotent-stem-cell–based-mapping-of-b-globin-expression-throughout-human-erythropoietic-development.pdf
News Richard presents his work at the International Symposium on Amyloidosis in Kumamoto, Japan adminApril 13, 2018
The Lab Murphy lab members with Dr. Joel Buxbaum of The Scripps Research Institute adminApril 13, 2018
News Murphy lab publishes an improved protocol for generating HSPCs from iPSCs in Stem Cells CLICK HERE TO ACCESS ARTICLEadminApril 13, 2018
Notch and Aryl Hydrocarbon Receptor Signaling Impact Definitive Hematopoiesis from Human Pluripotent Stem Cells http://murphylaboratory.com/wp-content/uploads/2022/06/Notch-and-Aryl-Hydrocarbon-Receptor-Signaling-Impact-Definitive-Hematopoiesis-from-Human-Pluripotent-Stem-Cells.pdf
News Richard is awarded a Junior Researcher Travel Award for the XVIth International Symposium on Amyloidosis in Kumamoto, Japan Click here to learn more about the Amyloidosis FoundationadminJanuary 16, 2018